One hot start-up sector in Germany at the moment is products made from the cannabis derivative cannabidiol or CBD. Evidence suggests that CBD can alleviate disorders ranging from anxiety and insomnia to epilepsy without creating dependence or having intoxicating effects.
Industries / Life Sciences
Coronavirus may have dominated the headlines last year, but Germany’s pharmaceutical companies were busy fighting disease on a number of fronts.
Pharmaceuticals colossus Bayer has partnered with German biotech company CureVac in the latter’s development of a vaccine to combat the coronavirus.
Finnish forest industry company UPM has begun construction a one-of-a-kind bio-refinery in the city of Leuna in the eastern German regional state of Saxony-Anhalt.
SKAN AG Group celebrated the groundbreaking ceremony for the next big expansion of its corporate site on the premises of the former lignite mine Görlitz/Hagenwerder in October 2020.
Medical products „Made in Germany“ are used worldwide. In the corona crisis, German medtech companies have proven that the industry is able to react very quickly to extraordinary situations and meet global requirements at short notice. The German government is strengthening this innovative power through targeted stimulus. Watch our video to learn more.
The two leading German biotech companies producing vaccines against Covid-19 have both reached important milestones.
The world is waiting anxiously as the first coronavirus vaccines are being approved and tested for approval. But companies responsible for the logistics of getting those vaccines to people, once they are admitted for use, are already springing into action.
As Europe’s largest medical biotech market, Germany continues to attract foreign investment thanks to its many established companies and dynamic start-up sector. Gradian Diagnostics’ recent acquisition of Molzym is a fine example of international matchmaking, facilitated by Germany Trade & Invest.
Amidst the coronavirus pandemic restrictions, some companies managed to buck the trend and reel in some serious capital. Not surprisingly, they were led by medtechs, including the two firms widely known for working on Covid-19 vaccines.